Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 09, 2025 06:00 ET | Source: Artax Biopharma

Artax Biopharma presents Phase 2a results for oral Nck modulator AX-158 in late-breaking session at the Society for Investigative Dermatology 2025 Annual Meeting

First small molecule to modulate the fundamental mechanism of T cell activation underlying autoimmune pathology Statistically significant improvements in T cell and psoriasis-related biomarkers...
April 23, 2025 12:00 ET | Source: Artax Biopharma

Artax Biopharma to present Phase 2a data on Nck modulator AX-158, establishing novel mechanism of action in autoimmune disease at the 2025 SID Annual Meeting

Late breaker abstract presentation to showcase clinical validation of first-in-class oral small molecule AX-158 in cohort of patients with psoriasis Full dataset to expand on previously announced...
March 07, 2025 12:09 ET | Source: Artax Biopharma

Artax Biopharma Presents New Preclinical Data on Nck Modulators at 2025 AAD Annual Meeting

Nck modulator reduced evidence of inflammation in an animal model of dermal irritation Compelling preclinical data support continued development of Nck modulators in atopic dermatitis CAMBRIDGE,...
March 03, 2025 09:00 ET | Source: Artax Biopharma

Artax Biopharma to present on first-in-class Nck modulator at the 2025 AAD Annual Meeting

CAMBRIDGE, Mass., March 03, 2025 (GLOBE NEWSWIRE) -- Artax Biopharma, Inc., a clinical-stage biotechnology company focused on transforming the treatment of autoimmune diseases, today announces an...